Traditional vaccines such as Novavax and Covax-19 could increase vaccination rates and stop vaccine hesitancy.
Reuters reported that Novavax Inc’s (NVAX.O) COVID-19 vaccine generates an immune response against the Omicron variant making it superior to the mRNA competitors that have to be boosted with jabs to create antibodies.
When will the Australian TGA approve Novavax and our very own Covax-19 created by Professor Nikolai Petrovsky from Melbourne?
Recommended for you
